Status:
UNKNOWN
ReMindCare App for Patients From First Episode of Psychosis Unit.
Lead Sponsor:
Instituto de Investigacion Sanitaria INCLIVA
Collaborating Sponsors:
University of Valencia
Universitat Politècnica de València
Conditions:
Psychosis
Schizophrenia
Eligibility:
All Genders
17-65 years
Phase:
NA
Brief Summary
ReMindCare is an app designed by the Unit of Psychiatry at the Clinical Hospital of Valencia in liaison with the Polytechnic University of Valencia. This e-Health app gathers information about the cl...
Detailed Description
Baseline surveys: Baseline surveys will be administered. In this first evaluation, sociodemographic information and clinical information such as diagnosis, pattern of antipsychotic treatment, number ...
Eligibility Criteria
Inclusion
- Patients from the FEPU at Clinic Hospital of Valencia.
- Diagnosis of Psychotic Disorder following DSMI-5 \[32\] criteria.
- Age between 17 to 65 years old.
- Owning a smartphone which allows the correct installation and functioning of the App.
- Owning a smartphone which allows internet connection (not necessary permanent)
Exclusion
- Severe Mental Disability
- Lack of abilities in using and mastering mobile devices and internet.
- Not to sign informed consent sheet.
- Level of Spanish not fluid.
- Do not have an own smartphone.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03807388
Start Date
September 1 2019
End Date
September 1 2023
Last Update
January 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
INCLIVA
Valencia, Spain, 46010